Creating artificial enzymes to selectively break down carbohydrates
Artificial Glycosidase with Controlled Selectivity
This study is working on creating special tools that can help scientists better understand sugars in our bodies, which are important for many health issues, so they can find new ways to treat related conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa State University NIH-funded |
| Lab location | 1 site (Ames, United States) |
| Project ID | NIH-10792684 on NIH RePORTER |
What this research studies
This research focuses on developing artificial glycosidases, which are enzymes designed to selectively hydrolyze carbohydrates. By utilizing protein-sized molecularly imprinted nanoparticles, the researchers aim to create synthetic lectins that can recognize and bind to various sugars and peptides in biological systems. This approach addresses the challenges posed by the complexity and diversity of glycans, which are crucial in many biological processes and diseases. The goal is to enhance the tools available for studying carbohydrates, potentially leading to better understanding and treatment of related health conditions.
Who could benefit from this research
Good fit: Patients with conditions related to carbohydrate metabolism or diseases influenced by glycan interactions would be ideal candidates to benefit from this research.
Not a fit: Patients with conditions unrelated to carbohydrate metabolism or those not affected by glycan interactions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic tools for diseases linked to carbohydrate metabolism.
How similar studies have performed: Previous research has shown promise in using synthetic lectins for carbohydrate recognition, indicating that this approach may lead to significant advancements in glycoscience.
Where this research is happening
Ames, United States
- Iowa State University — Ames, United States (Active)
Researchers
- Principal investigator: Zhao, Yan — Iowa State University
- Study coordinator: Zhao, Yan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.